Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance

NCT03725033 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT03725033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03725033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Completed
Start date
October 10, 2018
Completion date
March 23, 2020
Enrollment
538 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

impaired glucose tolerance